-
Wednesday, 02/26/2020
Dr. Antoni Torres interviewed by TV3 news about the Coronavirus
As pulmonologist expert on respiratory infections and full professor at School of Medicine on respiratory diseases, he highlights what we need to know about the Covid-19
Dr. Antoni Torres' complete interview is available at TV3 website:
-
Tuesday, 02/25/2020
Dr. Roberto Cabrera awarded for the Best Poster at the 25th International Symposium on Infections in the Critically Ill Patients
The Symposium was held in Barcelona on Feruary 13-14 of 2020 at the School of Medicine (University of Barcelona)
International experts in the field of respiratory infections in the critically ill patients attended this interesting symposium organized by: Antonio Artigas, Jean Carlet, Ricard Ferrer, Michael Niederman and Antoni Torres.
Dr. Roberto Cabrera and col. (Cabrera R, Fernandez-Barat L, Motos A, Lopez-Aladid R, Vázquez N, Panigada M, Álvarez-Lerma F, López J, Muñoz L, Castro P, Vila J and Torres A) were awarded with the Best poster award: Molecular characterization of Staphylococcus aureus clinical strains from endotracheal tubes of patients with ICU-acquiered pneumonia, a work that has been recently accepted for publication in Antimicrobial Resistance and Infection Control.
-
Wednesday, 02/12/2020
Dr. Antoni Torres, awarded for research excellence " ICREA Acadèmia " 2019
Prof. Antoni Torres was recently honored by the ICREA Acadèmia 2019 Program for excellence in research in the area "Life & Medical Sciences".
ICREA Acadèmia is a program to support research exclusively for active teachers of public universities. The ICREA recognition involves a priority dedication to research for five years and provides the winner with an annual allowance to be preferentially allocated to research activities. -
Sunday, 01/26/2020
Patricia Oscanoa selected by the research contracts “Emili Letang-Josep Font” in Prof. Antoni Torres research group
This research contracts selects the best scientific projects in medical residents during their last year in Hospital Clinic de Barcelona.
The clinical research contracts “Emili Letang-Josep Font” has been resolved. Dra. Patricia Oscanoa: From Peru, she lives in Barcelona. She joined the Bronchiectasis Research Group directed by Prof. Antoni Torres 3 years ago.This program offers the opportunity to develop a research project with a 2 year temporary contract and professional category of specialist. During this time the researcher must focus intensively on the activity related to the project, which will also constitute the material of her doctoral thesis.The objective of the contracts is to capture young medical researchers, a profile that is especially necessary in the environment of Hospital Clinic de Barcelona.The project aimed at studying the prognostic value of Biofire Film Array pneumonia panel in bronchiectasis exacerbations is related with a FIS project 2018 directed by Prof. Antoni Torres Martí, research group leader, and Dr. Laia Fernandez-Barat, coordinator of the research microbiology laboratory. -
Saturday, 01/25/2020
Prof. Antoni Torres Martí group leader of IAMR research group on the 7 out of 20 best Spanish researchers in Medicine
An interesting article published in:
https://www.lainformacion.com/asuntos-sociales/massague-a-la-cabeza-del-ranking-de-los-mejores-cientificos-espanoles/6536647/https://www.lainformacion.com/asuntos-sociales/massague-a-la-cabeza-del-ranking-de-los-mejores-cientificos-espanoles/6536647/https://www.lainformacion.com/asuntos-sociales/massague-a-la-cabeza-del-ranking-de-los-mejores-cientificos-espanoles/6536647/
Highlights Dr. Antonio Torres, the IAMR group leader, on the 7th position of the 20 most important Spanish researchers in Medicine.
-
Friday, 12/20/2019
IAMR achieved funding for one project at the health national call 2019 (FIS)
The success warrants funding for the next three years in the laboratory and in the Community-Acquired Pneumonia research line
Dr. Catia Cillóniz and Dr. Nestor Soler co-leaded the project entitled “Phenotypes related to short and long-term outcomes in community-acquired pneumonia ”. This project achieved 183.000 euros.
-
Monday, 11/25/2019
Kasra kiarostami joins the IAMR group for his UB Master in Translational Medicine
As a veterinarian, he is deeply involved in the study of ETT-biofilm after Telavancin treatment in the pig animal model
Kasra kiarostami holds a Degree in veterinary of parasitology by the University of Azad since 2013 and he is currently performing a research stay associated with the Master in Translational Medicine-MSc at the Cellex laboratory, School of Medicine, University of Barcelona. He joined the IAMR group in November 2019 in order to do his Master Thesis, which he will defend in June 2020.
He works on a randomized clinical trial focused on the study focused on the effect of telavancin in comparison with linezolid on endotracheal tube biofilm in the IAMR pig model with methicillin-resistant Staphylococcus aureus pneumonia. This study is coordinated by Dr. Laia Fernàndez-Barat and Prof. Antoni Torres, as its Principal Investigator, and isbased on previous studies by the research group in the porcine animal model.
Kasra also works in the microbiological analysis of respiratory samples from various projects of the animal model. -
Friday, 07/12/2019
Prof. Antoni Torres considered Top Expertise in Respiratory Tract Infections Worldwide
Information available online and based on 98,806 articles published since 2008
Prof. Antoni Torres, the IAMR group leader, is very high ranked on the source:
http://www.expertscape.com/ex/respiratory+tract+infections in which a ranking for country, city or institution are also available based on 98,806 scientific and clinical articles published since 2008.
-
Monday, 06/17/2019
First scientific Workshop for patients with bronchiectasis
The workshop was sponsorized by SEPAR pacientes, GlaxoSmithKline (GSK), Mundipharma and Chiesi and it was organized by the Dr. Torres bronchiectasis group at Hospital Clínic
Ninety five patients attended the last 31st of May the first scientific Workshops addressed to patients who suffered from bronchiectasis. The Workshops program included the inaugural welcome message from Dr. Antoni Torres, the head of the respiratory ICU and bronchiectasis monographic consultation at the Hospital Clinic and Dr. Joan Albert Barberà, Head of Pneumology Service of the Hospital Clinic. Dr. Carmen Hernández, as responsible for “dispositivo transversal de hospitalización a domicilio” also participated during the opening. Then, the program included three scientific presentations by Dr. Rosanel Amaro, coordinator of the bronchiectasis monographic consultation at the Hospital Clinic, Victoria Alcaraz, specialist in respiratory physiotherapy focused in bronchiectasis, Dr. Laia Fernández-Barat, coordinator of the research microbiology laboratory, Marta Almagro, a very involved patient diagnosed from bronchiectasis when she was a child and María Rodríguez, representative of the association of patients with hypertension.
-
Monday, 06/17/2019
The IAMR research team has been successful in the 2018 call for the Spanish Society of Pneumology and Thoracic Surgery (SEPAR)
The SEPAR 2018 Grants of Fundació Respira (Spanish Lung Foundation) will invest around 600.000 euros in research
Antoni Torres, Miquel Ferrer, Enric Barbeta, Laia Fernández and Catia Cilloniz and obtained funding from the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) - Fundació Respira grants (http://www.separ.es) to carry out their research projects in the field of respiratory diseases.
Prof. Dr. Antoni Torres obtained a SEPAR 2018 grant for his project: Cardiac injury due to severe pneumococcal pneumonia: an evaluation of the effects of corticosteroids and macrolides.
Dr. Miquel Ferrer and Enric Barbeta obtained a SEPAR 2018 grant for his project: Mechanical Power, Driving Pressure and Biotrauma in the acute respiratory distress syndrome.
Dr. Laia Fernández-Barat obtained a SEPAR 2018 grant for his project: The importance of Pseudomonas aeruginosa biofilms in the exacerbations of patients with bronchiectasis with or without chronic obstructive pulmonary diseases.
Dr. Catia Cilloniz obtained a SEPAR 2018 grant for his project: Characterization of the acquired immune response in patients with community acquired pneumonia.
SEPAR-Fundació Respira awards a number of grants each year with the aim of encouraging research in the field of respiratory disease.
